Furthermore, a tumour initiation assay was performed to further evaluate the tumorigenicity capacity of BC cells in vivo, and knockdown of LUCAT1 in BC cells decreased the size (Fig. 3D), weight (Fig. 3E) and incidence (Fig. 3F and G) of xenografts. The gene discussed is LUCAT1; the disease is breast cancer.